Investing.com -- Brazil’s economy added 147,358 net formal jobs in August, according to data released by the Labor Ministry on Monday, falling short of the analyst estimate of 160,000 new positions.

Dividend investors seeking both income and growth potential have compelling options in today’s market, according to Investing.com’s WarrenAI analysis. The AI-powered system has identified five ...

Investing.com -- UBS initiated coverage of Core & Main Inc with a Buy rating and a price target of $65, saying the recent pullback in the stock offers an attractive entry point as growth accelerates ...

Samsung is expected to provide a major boost. Mizuho wrote that it foresees “EUV demand increase from Samsung in 2026 due to ...

Investing.com -- Knorex Ltd. (NYSE:KNRX) started trading on the NYSE American Monday at $4 per share, matching its initial public offering price. The AI-driven digital advertising technology company ...

Investing.com -- Morgan Stanley sharply raised its price targets and earnings forecasts for Western Digital and Seagate ...

Investing.com -- Outlook Therapeutics Inc (NASDAQ:OTLK) stock jumped 11.3% Monday following a productive Type A meeting with the U.S. Food and Drug Administration (FDA) regarding its biologics license ...

Investing.com -- German artificial intelligence startup Black Forest Labs is in discussions to raise between $200 million and $300 million in funding that could value the company at around $4 billion, ...

Investing.com -- Kala Pharmaceuticals Inc (NASDAQ:KALA) stock plummeted 89% on Monday after the company announced its CHASE Phase 2b clinical trial for KPI-012 failed to meet its primary endpoint for ...

U.S. Bancorp was similarly cut to Equal-weight. Morgan Stanley’s $56 price target implies 13% upside, again short of peers.

Investing.com -- Comscore Inc (NASDAQ:SCOR) stock surged 61% on Monday after the media measurement company announced a significant recapitalization agreement with its preferred stockholders that ...

Investing.com -- RAPT Therapeutics Inc (NASDAQ:RAPT) stock gained 3.5% Monday after the company announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND ...